Insights

Roblox Sexual Abuse Litigation Sees Major Surge
The wave of litigation facing Roblox Corporation over allegations of child sexual exploitation and grooming has intensified sharply in November 2025. New filings—from individual families to state attorneys general—paint a consistent picture: predators are using the...

Social Media Addiction Lawsuits Surge Past 2,100 as Federal MDL Expands
November 2025 — Northern District of California The ongoing social media addiction lawsuits continue to accelerate nationwide, with another 100 new cases added in the past month. The Social Media Addiction MDL (In re Social Media Adolescent Addiction/Personal Injury...

Weight-Loss Drug and Birth-Control MDLs Redefine Pharmaceutical Litigation in 2025
Two rapidly expanding multidistrict litigations, the GLP-1 Receptor Agonists MDL (3094) and the Depo-Provera Brain Tumor MDL (3140), are reshaping pharmaceutical mass-tort practice across the United States. GLP-1 Drug Litigation: Ozempic, Wegovy, and Mounjaro Under...

PFAS Firefighting Foam Lawsuits Surge as Tens of Thousands of New Cases Filed Nationwide
The ongoing multidistrict litigation (MDL 2873) over Aqueous Film-Forming Foam (AFFF) has entered an unprecedented phase. Between August and September 2025, more than 37,000 new personal-injury cases were filed in the U.S. District Court for the District of South...

Boy Scouts Abuse Survivors Petition Supreme Court to Review $2.46 Billion Bankruptcy Settlement
A group of Boy Scouts of America (BSA) abuse survivors has asked the U.S. Supreme Court to review the organization’s $2.46 billion bankruptcy settlement, arguing that the plan unlawfully prevents them from pursuing separate lawsuits against third parties such as local...

The New Era of Mass Torts: Institutional Betrayal and Digital Exploitation
The Age of Invisible Harm The mass torts of the past targeted defective drugs, toxic spills, and dangerous products. The next generation targets institutions and platforms that allowed abuse, addiction, and exploitation to thrive. Today’s plaintiffs aren’t poisoned by...
